Optogenetic Immunomodulation: Shedding Light on Antitumor Immunity.
Microbial opsin-based optogenetic tools have been transformative for neuroscience. To extend optogenetic approaches to the immune system to remotely control immune responses with superior spatiotemporal precision, pioneering tools have recently been crafted to modulate lymphocyte trafficking, inflammasome activation, dendritic cell (DC) maturation, and antitumor immunity through the photoactivation of engineered chemokine receptors and calcium release-activated calcium channels. We highlight herein some conceptual design strategies for installing light sensitivities into the immune signaling network and, in parallel, we propose potential solutions for in vivo optogenetic applications in living organisms with near-infrared light-responsive upconversion nanomaterials. Moreover, to move beyond proof-of-concept into translational applications, we discuss future prospects for integrating personalized immunoengineering with optogenetics to overcome critical hurdles in cancer immunotherapy.
Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Peng
P
Tan
Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
Lian
L
He
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: gang.han@umassmed.edu.
Gang
G
Han
Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA; Department of Medical Physiology, College of Medicine, Texas A&M University Health Science Center, Temple, TX 76504, USA. Electronic address: yzhou@ibt.tamhsc.edu.
Yubin
Y
Zhou
D000818:Animals; D057005:Bioengineering; D006801:Humans; D056747:Immunomodulation; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D062308:Optogenetics
CRAC channel; cancer immunotherapy; genome engineering; immune response; optogenetics; upconversion nanoparticle
J Cell Sci. 2008 Mar 1;121(Pt 5):551-9
18287584
EMBO J. 2003 Aug 1;22(15):3825-32
12881417
Nat Rev Clin Oncol. 2016 Jun;13(6):370-83
27000958
Nat Commun. 2014 Jul 14;5:4404
25019686
Immunity. 2013 Jul 25;39(1):1-10
23890059
Nat Chem Biol. 2016 Jun;12(6):425-30
27065233
Chem Rev. 2014 May 28;114(10):5161-214
24605868
Elife. 2016 Jan 12;5:e11860
26754770
ACS Nano. 2016 Apr 26;10(4):3881-3885
27077481
Front Immunol. 2015 Aug 10;6:410
26322043
Sci Transl Med. 2014 Feb 19;6(224):224ra25
24553386
Nature. 1997 Apr 24;386(6627):855-8
9126747
Nature. 2009 Sep 3;461(7260):104-8
19693014
PLoS One. 2013 Aug 07;8(8):e70861
23951027
Nat Rev Cancer. 2012 Mar 22;12(4):265-77
22437871
Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12064-8
26418181
Nature. 2009 Oct 15;461(7266):997-1001
19749742
Nat Rev Mol Cell Biol. 2014 Aug;15(8):551-8
25027655
Nat Chem Biol. 2014 Mar;10(3):196-202
24413462
Nat Rev Mol Cell Biol. 2016 Jan;17(1):5-15
26670017
Nat Commun. 2015 Jul 17;6:7826
26184105
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1442-51
26929367
Nat Methods. 2016 Jul;13(7):591-7
27159085
Nat Biotechnol. 2015 Oct;33(10):1092-6
26368050
Nat Rev Mol Cell Biol. 2012 Sep;13(9):549-65
22914293
PLoS Genet. 2014 Mar 20;10(3):e1004218
24651064
Cell Death Differ. 2015 Feb;22(2):237-46
25190142
Cell Syst. 2016 Apr 27;2(4):283-8
27135540
Nat Methods. 2015 Oct;12(10):969-74
26280330
Nat Methods. 2013 Mar;10(3):249-52
23377377
Nat Rev Drug Discov. 2016 Apr;15(4):235-47
26965203
Nat Biotechnol. 2015 Jul;33(7):755-60
26076431
Annu Rev Immunol. 2015;33:291-353
25861976
Nat Biotechnol. 2009 Oct;27(10):941-5
19801976
Science. 2016 Apr 8;352(6282):227-31
26966191
Chem Biol. 2014 Jul 17;21(7):903-12
24981772
Nat Commun. 2016 Feb 08;7:10624
26853913
Science. 2015 Oct 16;350(6258):aab4077
26405231
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6371-6
24733886
Cell. 2002 May 31;109(5):611-23
12062104
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E358-67
26733686
Annu Rev Immunol. 2016 May 20;34:203-42
26907216
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):112-7
25535392
Physiol Rev. 2015 Oct;95(4):1383-436
26400989
Nat Commun. 2014 Sep 18;5:4925
25233328
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14467-72
26598681
Nat Methods. 2012 Mar 04;9(4):379-84
22388287
Nat Chem Biol. 2008 Aug;4(8):491-7
18604202
Chem Biol. 2015 Feb 19;22(2):169-74
25619936
J Am Chem Soc. 2013 Sep 18;135(37):13914-26
23931685
Nat Methods. 2010 Dec;7(12):973-5
21037589
Elife. 2015 Dec 08;4:
26646180
Biochim Biophys Acta. 2014 Mar;1840(3):964-9
24269537
Nat Rev Clin Oncol. 2016 May;13(5):273-90
26977780
Biophys J. 2008 Feb 15;94(4):1203-15
17921221
Biol Cell. 2013 Feb;105(2):59-72
23157573
Cell. 2015 Jul 30;162(3):662-74
26189679
Sci Transl Med. 2012 Aug 22;4(148):148rv9
22914624
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2316-23
22847441
EMBO J. 2014 Aug 1;33(15):1713-26
24986882
Sci Transl Med. 2016 Mar 2;8(328):328rv4
26936508
Nat Biotechnol. 2015 Dec;33(12):1280-1286
26551059
Adv Drug Deliv Rev. 2013 May;65(5):744-55
22626980
Angew Chem Int Ed Engl. 2016 May 17;55(21):6339-42
27101018
Trends Biotechnol. 2015 Feb;33(2):92-100
25529484
Nat Rev Cancer. 2016 Feb;16(2):121-6
26822578
Nature. 2015 Jul 9;523(7559):231-5
25970248
Nat Methods. 2016 Sep;13(9):755-8
27427858
Cell. 2014 Mar 13;156(6):1207-1222
24630723
Nat Commun. 2015 Feb 24;6:6256
25708714